Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
EQL Pharma Oy
OY
Active
Y-tunnus 2136140-3
Pl 114, 00121
Helsinki
Activities of agents involved in the wholesale of other particular products
·
NACE 4618
Est. 2007 · 18 years old
— employees
Share
Finland
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
EQL Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
0M
2025
0M
2026
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
0M
0%
2026
Income statement
EUR thousands
Item
2022
2023
2024
2025
2026
Revenue
5
5
5
4
5
Staff expenses
—
−0
−0
−0
−0
EBITDA
2
2
1
−0
−0
Depreciation & amort.
—
−0
−0
−0
−0
EBIT
2
2
1
−0
−0
Net financials
—
0
0
0
0
Profit before tax
2
2
1
−0
−0
Tax
−0
−0
−0
−0
−0
Net profit
2
2
1
−0
−0
Balance sheet
EUR thousands
Item
2022
2023
2024
2025
2026
Total assets
12
12
14
14
14
Equity
11
12
14
13
13
Long-term debt
—
0
0
0
0
Short-term debt
1
0
0
0
0
Total debt
1
0
0
0
1
Financial ratios
5-year trend
EBITDA-margin
-5.1%
This company
15.8%
Market median
-132% vs market
2022
2026
Soliditetsgrad
92.3%
This company
38.2%
Market median
+142% vs market
2022
2026
Egenkapitalforrentning
-1.7%
This company
18.4%
Market median
-109% vs market
2022
2026
Nettoresultatgrad
-5.1%
This company
8.1%
Market median
-163% vs market
2022
2026
Aktivomsætning
0.31×
This company
1.12×
Market median
-72% vs market
2022
2026
Gæld/egenkapital
0.08×
This company
0.62×
Market median
+87% vs market
2022
2026
Annual reports & filings
Annual report 2026
Filed via PRH / YTJ · Period 2025-04-01 – 2026-03-31
View
PDF
Annual report 2025
Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
View
PDF
More on EQL Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
